Coronavirus Cell Entry Occurs through the Endo-/Lysosomal Pathway in a Proteolysis-Dependent Manner-Reference-Cited by-同舟云学术

Coronavirus Cell Entry Occurs through the Endo-/Lysosomal Pathway in a Proteolysis-Dependent Manner

Published:2014-11-06 Issue:11 Volume:10 Page:e1004502
ISSN:1553-7374
Container-title:PLoS Pathogens
language:en
Short-container-title:PLoS Pathog

Author:

Burkard Christine,Verheije Monique H.,Wicht Oliver,van Kasteren Sander I.,van Kuppeveld Frank J.,Haagmans Bart L.,Pelkmans Lucas,Rottier Peter J. M.,Bosch Berend Jan,de Haan Cornelis A. M.

Publisher

Public Library of Science (PLoS)

Subject

Virology,Genetics,Molecular Biology,Immunology,Microbiology,Parasitology

Reference105 articles.

1. Anti-glycoprotein D antibodies that permit adsorption but block infection by herpes simplex virus 1 prevent virion-cell fusion at the cell surface;AO Fuller;Proceedings of the National Academy of Sciences of the United States of America,1987

2. Microtubule-mediated transport of incoming herpes simplex virus 1 capsids to the nucleus;B Sodeik;The Journal of cell biology,1997

3. Factors in fusion of cells by HVJ;Y Okada;Current topics in microbiology and immunology,1969

4. Endocytosis of HIV: anything goes;M Permanyer;Trends in microbiology,2010

5. pH-independent HIV entry into CD4-positive T cells via virus envelope fusion to the plasma membrane;BS Stein;Cell,1987

Cited by 328 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SARS-CoV-2 biology and host interactions;Nature Reviews Microbiology;2024-01-15

2. Genome-wide bioinformatics analysis of human protease capacity for proteolytic cleavage of the SARS-CoV-2 spike glycoprotein;Microbiology Spectrum;2024-01-08

3. Broad spectrum post-entry inhibitors of coronavirus replication: Cardiotonic steroids and monensin;Virology;2024-01

4. In silico anti-viral assessment of phytoconstituents in a traditional (Siddha Medicine) polyherbal formulation – Targeting Mpro and pan-coronavirus post-fusion Spike protein;Journal of Traditional and Complementary Medicine;2024-01

5. An Update on SARS-CoV-2 Clinical Trial Results—What We Can Learn for the Next Pandemic;International Journal of Molecular Sciences;2023-12-26